Details for New Drug Application (NDA): 210401
✉ Email this page to a colleague
The generic ingredient in ACYCLOVIR is acyclovir sodium. There are fifty-six drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the acyclovir sodium profile page.
Pharmacology for NDA: 210401
Mechanism of Action | DNA Polymerase Inhibitors |
Medical Subject Heading (MeSH) Categories for 210401
Suppliers and Packaging for NDA: 210401
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ACYCLOVIR | acyclovir | TABLET;ORAL | 210401 | ANDA | A-S Medication Solutions | 50090-6578 | 50090-6578-0 | 35 TABLET in 1 BOTTLE (50090-6578-0) |
ACYCLOVIR | acyclovir | TABLET;ORAL | 210401 | ANDA | A-S Medication Solutions | 50090-6578 | 50090-6578-2 | 70 TABLET in 1 BOTTLE (50090-6578-2) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 400MG | ||||
Approval Date: | Mar 7, 2018 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 800MG | ||||
Approval Date: | Mar 7, 2018 | TE: | AB | RLD: | No |
Complete Access Available with Subscription